Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Study of Longitudinal Plasma PD-L1 Testing With Immunotherapy in Lung Cancer

NCT06849518 is registered in ClinicalTrials.gov with Ballad Health as lead sponsor.

NCT NCT06849518
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06849518 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Study of Longitudinal Plasma PD-L1 Testing With Immunotherapy in Lung Cancer
Lead sponsor
Ballad Health
Phase
Not applicable
Overall status
Recruiting
Start date
February 11, 2025
Completion date
March 1, 2027
Enrollment
30 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

lung cancer (nsclc)